Nasopharyngeal Cancer Screening: Methods, Target Populations, and Next Steps

Area of Science:

• Oncology
• Virology
• Molecular Diagnostics

Background:

• Nasopharyngeal carcinoma (NPC) poses a significant health challenge, with early detection being key to improving patient outcomes.
• Current screening methods require optimization for greater accuracy and accessibility.

Purpose of the Study:

• To review and evaluate current and emerging strategies for nasopharyngeal carcinoma (NPC) screening.
• To highlight the role of molecular diagnostics and biomarkers in early NPC detection.

Main Methods:

• Review of current literature on NPC screening strategies.
• Emphasis on plasma Epstein-Barr virus (EBV) DNA testing and next-generation sequencing for molecular profiling.
• Discussion of EBV antibody assays, novel serological markers (e.g., anti-BNLF2b), genetic variants, and noninvasive sampling techniques.

Main Results:

• Plasma EBV DNA testing, enhanced by next-generation sequencing, improves specificity in NPC detection.
• Novel EBV antibody assays and biomarkers aid in risk stratification and potential mortality reduction.
• Emerging noninvasive methods like transoral brushing offer new avenues for early diagnosis.

Conclusions:

• Integrating advanced molecular profiling, serological markers, and noninvasive techniques can lead to more effective and targeted NPC screening.
• Optimized screening in high-risk populations promises reduced NPC mortality and improved patient quality of life.